Period Ending | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 |
Total Revenue
|
30,764,707
|
29,527,552
|
25,914,238
| Cost of Revenue | 13,209,329 | 12,612,022 | 11,422,046 | |
Gross Profit
|
17,555,378
|
16,915,530
|
14,492,192
| |
|
Operating Expenses |
|
Research Development | 2,743,733 | 2,688,811 | 2,505,649 |
|
Selling General and Administrative | 8,405,904 | 8,435,624 | 7,407,998 |
|
Non Recurring | 170,000 | 97,256 |
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
6,235,741
|
5,693,839
|
4,578,545
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,477,689 | 571,924 | 484,245 |
|
Earnings Before Interest And Taxes | 7,713,430 | 6,384,760 | 5,062,790 |
|
Interest Expense | 519,656 | 528,474 | 593,142 |
|
Income Before Tax | 7,193,774 | 5,856,286 | 4,469,648 |
|
Income Tax Expense | 1,447,936 | 1,122,070 | 863,334 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 5,745,838 | 4,734,216 | 3,606,314 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
| 146,503 |
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
5,745,838
|
4,880,719
|
3,606,314
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
$5,745,838
|
$4,880,719
|
$3,606,314
|
|